search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Athira Pharma, Inc.

    (NASDAQ:ATHA)

    $2.75

    $-0.10

    -3.51%

    Athira Pharma, Inc. Chart

    ATHA Stock Price Today

    Athira Pharma, Inc. (ATHA) stock declined over -3.51% intraday to trade at $2.75 a share on NASDAQ. The stock opened with a gain of 4.17% at $2.82 and touched an intraday high of $2.83, falling -3.51% against the last close of $2.85. The stock went to a low of $2.58 during the session.

    Stock Snapshot

    $2.85

    Prev. Close

    97.49 Million

    Market Cap

    $2.58

    Day Low

    $2.82

    Open

    37.59 Million

    Number of Shares

    $2.83

    Day High

    -

    P/E ratio

    -1.72

    EPS (TTM)

    6.74

    Cash Flow per Share

    8.23

    Free Float in %

    9.00

    Book Value

    4,787,184

    Volume

    Athira Pharma, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$2.82$2.83$2.58$2.754,788,800
    2022-06-22$2.64$3.1$2.53$2.8522,040,900
    2022-06-21$8.74$8.9$8.41$8.45355,000
    2022-06-17$8.28$8.998$8.13$8.6431,700
    2022-06-16$8.04$8.244$7.9$8.1221,800
    2022-06-15$8.09$8.42$7.96$8.22167,700
    2022-06-14$8$8.09$7.84$8.03141,400
    2022-06-13$7.95$8.24$7.81$8.05250,900
    2022-06-10$8.11$8.22$7.95$8.16170,000
    2022-06-09$9$9$8.35$8.36157,800

    Contact Details

    18706 North Creek Parkway
    Suite 104
    Bothell, WA 98011
    United States

    Webiste:ATHA

    425 620 8501

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryPharmaceuticals

    About Company

    Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. It also develops product candidates, which are in preclinical stage, including ATH-1019 for peripheral nervous system indications; and ATH-1020 for neuropsychiatric conditions. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.

    Frequently Asked Questions

    icon

    What is the current Athira Pharma, Inc. (ATHA) stock price?

    Athira Pharma, Inc. (NASDAQ: ATHA) stock price is $2.75 as of the last check on Thursday, June 23. During the trading session, ATHA stock reached the peak price of $2.83 while $2.58 was the lowest point it dropped to.

    icon

    ATHA's industry and sector of operation?

    The NASDAQ listed ATHA is part of Pharmaceuticals industry that operates in the broader Health Care sector. Athira Pharma, Inc. , a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation.

    icon

    Who are the executives of ATHA?

    Dr. Mark J. Litton M.B.A., MBA, Ph.D.
    Pres, CEO & Director
    Ms. Rachel P. Lenington M.B.A.
    Chief Operating Officer
    Mr. Mark F. Worthington J.D.
    Gen. Counsel & Corp. Sec.
    Ms. Glenna K. Mileson
    Chief Financial Officer

    icon

    What is the ATHA stock price today?

    ATHA stock traded closed the last session at $2.75, which is $-0.10 or -3.51% lower than its previous close of $2.85. ATHA's current trading price is 8.70% lower than its 52-week high of $16.65 where as its distance from 52-week low of 2.53% is -83.48%.

    icon

    How many employees does ATHA have?

    Number of ATHA employees currently stands at -. ATHA operates from 18706 North Creek Parkway, Suite 104, Bothell, WA 98011, United States.

    icon

    Link for ATHA official website?

    Official Webiste of $ATHA is: https://www.athira.com

    icon

    How do I contact ATHA?

    ATHA could be contacted at ATHA operates from 18706 North Creek Parkway, Suite 104, Bothell, WA 98011, United States, or at phone #425 620 8501 and can also be accessed through its website.

    icon

    How many shares of ATHA are traded daily?

    ATHA stock volume for the day was 4,787,184 shares while in the previous session number of ATHA shares traded was 4,788,800 . The average number of ATHA shares traded daily for last 3 months was 639.73 Thousands.

    icon

    How much did ATHA change today?

    The percentage change in ATHA stock occurred in the recent session was -3.51% while the dollar amount for the price change in ATHA stock was $-0.10.

    icon

    What price range ATHA stock been trading in?

    In the recent session, the day high for ATHA stock was $2.83 while the low for ATHA stock touched on the day was $2.58.

    icon

    What is the market cap of ATHA currently?

    The market value of ATHA currently stands at 97.49 Million with its latest stock price at $2.75 and 37.59 Million of its shares outstanding.